WHAT IT DOES:
Provides and distributes specialty medicine and clinical and in-home support services for the treatment of hemophilia, AAT deficiency, severe nutritional deficiencies and other afflictions.
HOW IT GREW:
A quick scan of BioRx’s recent activity shows a company aggressively expanding, both acquiring new businesses and premiering new products and services for its customers. In July, BioRx acquired Coagulife Pharmacy, which focuses on preventive physical therapy for hemophilia patients, which the company says is offered almost nowhere else in the U.S.
BioRx’s recent flurry of activity speaks to its commitment to serving its specialized corner of healthcare and its desire to remain at the forefront of the surging specialty pharmaceutical industry, officials say. According to the 2012 Specialty Drug Benefit Report released by the Pharmacy Benefit Management Institute, spending on specialty medicine has increased 15% to 20% over the past several years and is expected to continue to outpace nonspecialty spending in the future.
Location: Cincinnati Top executive: Co-Founder and President
Philip Rielly Number of employees: 169 Annual revenue (2011): $114.6 million Revenue growth (2006-11): 636.3% Website: biorx.com